INmune Bio, Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
4.400
-0.020 (-0.45%)
Dec 20, 2024, 4:00 PM EST - Market closed
INmune Bio Market Cap
INmune Bio has a market cap or net worth of $97.56 million as of December 20, 2024. Its market cap has decreased by -46.67% in one year.
Market Cap
97.56M
Enterprise Value
66.92M
1-Year Change
-46.67%
Ranking
Category
Stock Price
$4.40
Market Cap Chart
Since February 4, 2019, INmune Bio's market cap has increased from $77.82M to $97.56M, an increase of 25.36%. That is a compound annual growth rate of 3.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 97.56M | -51.92% |
| Dec 29, 2023 | 202.92M | 78.35% |
| Dec 30, 2022 | 113.78M | -37.49% |
| Dec 31, 2021 | 182.00M | -21.41% |
| Dec 31, 2020 | 231.57M | 270.69% |
| Dec 31, 2019 | 62.47M | -19.73% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Applied Therapeutics | 102.41M |
| Pyxis Oncology | 100.50M |
| electroCore | 100.09M |
| Adverum Biotechnologies | 98.60M |
| Journey Medical | 97.76M |
| MultiPlan | 97.35M |
| FONAR | 96.89M |
| Assembly Biosciences | 96.68M |